Saturday 17 October 2026
Export CRON’s income statement to Excel — free account
Cronos Group Inc.
CRON Healthcare Drug Manufacturers Specialty & Generic
Cronos Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.6 million, up 24.6% from fiscal 2024. In the quarter to June 2026, revenue grew 58.4%, EPS grew 190.0%, free cash flow grew 2,279.2% and total debt fell 4.71%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
3.22
0.02
+0.63%
Follow CRON
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | — | — |
P/E ratio |
0.00 | 19.52 | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 769.70 | 769.70 |
Altman Z-Score |
12.67 | 9.71 | 12.10 | 9.20 | 14.86 | 7.95 | 5.47 | 30.26 | — | — |
P/S ratio |
6.88 | 6.56 | 9.21 | 10.86 | 19.51 | 52.23 | 100.14 | 147.67 | 326.22 | 326.22 |
Altman Z″-Score (non-manufacturers) |
28.18 | 26.91 | 31.90 | 22.17 | 27.48 | 13.39 | 10.66 | 3.43 | 7.15 | 3.08 |
P/FCF ratio |
0.00 | 135.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
85.22 | 99.97 | 47.80 | (38.67) | (40.40) | (63.66) | (44.47) | 99.74 | (547.73) | (547.73) |
Beneish M-Score |
(2.05) | (2.59) | (2.26) | (3.99) | — | — | — | 0.19 | 8.31 | — |
P/B ratio |
0.88 | 0.69 | 0.73 | 0.83 | 1.09 | 1.43 | 1.36 | 12.05 | 15.42 | 15.42 |
Dividend Safety Score |
20 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.94 | 0.74 | 0.75 | 0.85 | 1.10 | 1.67 | 1.63 | 12.88 | 18.15 | 18.15 |
EV/Sales |
1.21 | (0.73) | (0.64) | 0.78 | 6.10 | 24.80 | 37.01 | 145.70 | 325.50 | 325.50 |
EV/EBITDA |
0.00 | 1.28 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
6.88 | (4.57) | 1.31 | (0.76) | (2.96) | (8.00) | (6.75) | (234.94) | (239.49) | (239.49) |
EV/FCF |
(936.49) | (15.12) | 1.20 | (0.72) | (2.74) | (6.43) | (5.19) | (18.38) | (27.54) | (27.54) |
Quick Ratio |
18.45 | 17.87 | 21.54 | 13.31 | 18.99 | 6.33 | 4.56 | 0.89 | 1.71 | 0.46 |
Current Ratio |
19.59 | 18.84 | 22.54 | 14.10 | 19.86 | 6.63 | 4.73 | 1.20 | 3.39 | 1.04 |
Net Debt/EBITDA |
337.10 | 12.77 | 11.21 | 9.23 | 5.50 | 7.62 | 12.79 | 1.23 | 3.45 | (0.31) |
Debt/Assets |
0.10% | 0.09% | 0.14% | 0.21% | 0.51% | 0.44% | 0.32% | 0.05% | 5.31% | 9.32% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.06 | 0.12 |
Asset Turnover |
0.12 | 0.10 | 0.07 | 0.07 | 0.04 | 0.02 | 0.02 | 0.09 | 0.06 | 0.01 |
Operating CF/Net income |
(2.74) | 0.46 | 0.58 | 0.53 | 0.39 | 1.98 | (0.11) | 0.35 | (2.23) | 5.44 |
Capex/Depreciation |
(1.83) | (1.41) | (0.42) | (0.38) | (0.80) | (3.17) | (9.95) | (45.73) | (42.87) | (3.98) |
Interest Coverage |
— | — | — | (4.97) | (21.99) | (9.22) | 4.33 | 257.12 | (16.73) | (8.95) |
| (0.84%) | 3.72% | (6.61%) | (13.63%) | (26.04%) | (4.23%) | 122.95% | (20.11%) | 4.17% | (1.91%) | |
| (0.80%) | 3.56% | (6.29%) | (12.93%) | (23.84%) | (3.64%) | 102.60% | (16.55%) | 3.48% | (1.52%) | |
ROIC |
(3.34%) | (18.89%) | (22.44%) | (25.38%) | (36.55%) | (26.26%) | (30.32%) | (10.70%) | (1.60%) | (3.89%) |
Return on Tangible Assets |
(0.91%) | 4.03% | (7.77%) | (17.71%) | (36.03%) | (5.41%) | 83.30% | (16.32%) | 3.32% | (8.24%) |
Average Days of Receivables |
142.42 | 90.47 | 126.92 | 121.51 | 136.48 | 148.14 | 182.42 | 167.40 | 380.37 | 70.56 |
Research and Development Expense of Revenue |
3.04% | 3.60% | 6.70% | 15.14% | 31.34% | 43.59% | 51.18% | 14.97% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
48.31% | 65.31% | 92.77% | 116.11% | 203.63% | 278.94% | 353.42% | 204.36% | 215.50% | 675.20% |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.02 | 0.02 | 0.01 | 0.13 | 0.14 | 0.05 | 0.13 | 0.30 |
Share Based Compensation of Revenue |
4.81% | 7.40% | 10.05% | 17.42% | 13.64% | 32.88% | 48.92% | 67.25% | 45.61% | 55.36% |
Graham Net Nets |
0.88 | 1.14 | 1.11 | 0.94 | 0.70 | 0.47 | 0.52 | 0.00 | 0.01 | 0.01 |
Graham Number |
0.00 | 2.60 | 0.00 | 0.00 | 0.00 | 0.00 | 22.48 | 0.00 | 0.33 | 0.00 |
Earnings Yield |
(0.38%) | 5.12% | (9.00%) | (18.00%) | (11.22%) | (2.88%) | 51.89% | (1.21%) | 0.13% | 0.13% |
Free Cash Flow Yield |
(0.02%) | 0.74% | (5.80%) | (9.97%) | (11.42%) | (7.39%) | (7.12%) | (5.37%) | (3.62%) | (3.62%) |
Revenue per Share |
0.38 | 0.31 | 0.23 | 0.23 | 0.20 | 0.13 | 0.08 | 0.07 | 0.02 | 0.01 |
Operating CF per Share |
0.07 | 0.05 | (0.11) | (0.24) | (0.41) | (0.41) | (0.42) | (0.04) | (0.03) | (0.06) |
Capex per Share |
(0.07) | (0.03) | (0.01) | (0.01) | (0.03) | (0.10) | (0.13) | (0.51) | (0.24) | (0.01) |
Free Cash Flow per Share |
0.00 | 0.01 | (0.12) | (0.25) | (0.45) | (0.51) | (0.55) | (0.56) | (0.28) | (0.08) |
Cash per Share |
2.17 | 2.25 | 2.26 | 2.33 | 2.71 | 3.67 | 4.86 | 0.14 | 0.05 | 0.03 |
Shareholders Equity per Share |
2.98 | 2.91 | 2.88 | 3.03 | 3.60 | 4.86 | 5.64 | 0.86 | 0.49 | 0.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.98 | 2.91 | 2.88 | 3.03 | 3.60 | 4.86 | 5.64 | 0.86 | 0.49 | 0.33 |
Free Cash Flow |
(0.19) | 5.69 | (46.26) | (93.98) | (165.88) | (180.26) | (169.23) | (96.10) | (37.22) | (6.04) |
Working Capital |
895.90 | 886.41 | 891.91 | 892.04 | 1,025.35 | 1,165.34 | 1,240.37 | 6.68 | 14.52 | 0.24 |
Capital Expenditures |
(26.06) | (13.15) | (3.42) | (5.03) | (12.26) | (35.39) | (38.95) | (88.59) | (32.94) | (1.15) |
Net Current Asset Value |
889.91 | 880.78 | 889.16 | 888.11 | 1,016.26 | 1,154.66 | 1,231.85 | 5.02 | 9.29 | (0.86) |
EV/EBIT |
0.00 | 1.12 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.18 | 0.11 | 0.04 | 0.06 | 0.16 | 0.76 | 1.64 | 7.31 | 10.46 | 2.75 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.10 | 0.07 | 0.14 | 0.22 | 0.21 | 0.06 | 0.02 | 0.02 | 0.02 | 0.03 |
Cash ROIC |
(0.01%) | 0.29% | (2.36%) | (4.65%) | (7.07%) | (6.00%) | (5.19%) | (55.69%) | (47.80%) | (19.44%) |
Accounts Receivable Turnover |
3.40 | 3.95 | 2.95 | 3.06 | 3.18 | 3.03 | 2.73 | 2.74 | 1.87 | 0.21 |
Accounts Payable Turnover |
5.86 | 6.35 | 6.47 | 6.40 | 6.04 | 2.66 | 1.21 | 0.30 | (0.70) | (0.31) |
Inventory Turnover |
2.10 | 2.90 | 2.21 | 2.03 | 2.39 | 1.77 | 1.82 | 0.71 | (0.40) | (0.18) |
Average Days of Payables |
50.68 | 67.03 | 58.77 | 57.14 | 44.10 | 97.33 | 311.63 | 2,053.53 | (913.42) | (298.22) |
Days of Inventory on Hand |
203.56 | 130.92 | 147.75 | 192.24 | 130.18 | 221.37 | 335.83 | 456.31 | (1,407.35) | (939.44) |
Average Receivables |
43.18 | 29.74 | 29.61 | 28.36 | 23.40 | 15.42 | 8.71 | 4.42 | 1.68 | 2.04 |
Average Payables |
14.31 | 14.55 | 11.65 | 11.14 | 15.23 | 27.32 | 34.27 | 19.66 | 3.48 | 3.48 |
Average Inventory |
39.95 | 31.82 | 34.03 | 35.18 | 38.40 | 41.02 | 22.71 | 8.37 | 6.08 | 6.20 |
Average Assets |
1,181.73 | 1,153.29 | 1,176.64 | 1,305.37 | 1,661.71 | 2,008.06 | 1,136.96 | 130.70 | 55.17 | 59.00 |
Average Common Equity |
1,126.97 | 1,103.55 | 1,118.54 | 1,237.62 | 1,521.22 | 1,728.60 | 948.79 | 107.59 | 46.03 | 47.12 |
Columns are period end dates